A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
Genentech, Inc.
National Cancer Institute (NCI)
Montefiore Medical Center
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
Eli Lilly and Company
OncoC4, Inc.
Seagen Inc.
KaliVir Immunotherapeutics
National Institutes of Health Clinical Center (CC)
Eastern Cooperative Oncology Group
International Agency for Research on Cancer
Arcus Biosciences, Inc.
Sotio Biotech Inc.
Radiopharm Theranostics, Ltd
Eli Lilly and Company
AstraZeneca
Terremoto Biosciences Inc.
Taiho Oncology, Inc.
Ensem Therapeutics
Centre Oscar Lambret
Merck Sharp & Dohme LLC
Mayo Clinic
Eli Lilly and Company
Neonc Technologies, Inc.
ViroMissile, Inc.
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Kaiser Permanente
Sichuan Enray Pharmaceutical Sciences Company
Tizona Therapeutics, Inc
National Institutes of Health Clinical Center (CC)
Daiichi Sankyo
Normunity AccelCo, Inc.
Jonsson Comprehensive Cancer Center
University of Colorado, Denver
MacroGenics
Amgen
Institut Curie
University of Oklahoma
Theravectys S.A.
Karolinska University Hospital
SystImmune Inc.
Daiichi Sankyo
Grey Wolf Therapeutics
Xinqiao Hospital of Chongqing
ImmunityBio, Inc.
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.